Left Menu
Development News Edition

Dr Reddy's settles litigation with Bristol Myers Squibb unit over generic cancer drug

Dr Reddy's Laboratories on Thursday said it has settled a litigation with a unit of Bristol Myers Squibb related to patents for Revlimid (lenalidomide) capsules, used to treat various kinds of cancer.

PTI | New Delhi | Updated: 17-09-2020 19:22 IST | Created: 17-09-2020 18:21 IST
Dr Reddy's settles litigation with Bristol Myers Squibb unit over generic cancer drug
Representative image

Dr Reddy's Laboratories on Thursday said it has settled a litigation with a unit of Bristol Myers Squibb related to patents for Revlimid (lenalidomide) capsules, used to treat various kinds of cancer. The Hyderabad-based company has settled litigation with Celgene, a wholly-owned subsidiary of Bristol Myers Squibb, Dr Reddy's Laboratories said in a statement.

In settlement of all outstanding claims in the litigation, Celgene has agreed to provide the company with a license to sell volume-limited amounts of generic lenalidomide capsules in the US beginning on a confidential date after March 2022 subject to regulatory approval, it added. The agreed-upon percentages are confidential, Dr Reddy's said.

The drug maker is already licensed to sell generic lenalidomide capsules in the US without volume limitation beginning on January 31, 2026, Dr Reddy's said. "We are pleased with the settlement agreement, and look forward to bringing a generic version of lenalidomide to market soon subject to regulatory approval for the benefit of patients," Dr Reddy's Laboratories North America Generics CEO Marc Kikuchi said.

Revlimid, a trademark of Celgene, is used to treat multiple myeloma and myelodysplastic syndromes.


TRENDING

OPINION / BLOG / INTERVIEW

New farm bills in India: Focusing on farms or farmers?

... ...

Kenya’s COVID-19 response: Chaos amid lack of information

Confusing numbers and scanty information on how effective curfews and lockdowns have been in breaking transmission have amplified coordination and planning challenges in Kenyas response to COVID-19. Without accurate data, it is impossible t...

Farkhad Akhmedov: Calculating the price of impunity from the law

In insistences such as the battle over the Luna, Akhmedov has resorted to extreme legal machinations to subvert the High Courts decision and keep his assets from being seized. ...

Guinea’s elections hearken back to the autocracy and violence of its past

... ...

Videos

Latest News

Pak warns India against any 'misadventure'

Pakistan said on Thursday that any misadventure by India will invite a full spectrum response by IslamabadForeign Office spokesman Zahid Hafeez Chaudhri made the comments while responding to questions during his weekly media briefing here. ...

HDFC Bank to handle salary accounts of Mumbai cops

The Mumbai Police will deposit salaries of their personnel in HDFC Bank, a leading private bank, from this month, replacing Axis Bank which handled their accounts so far, an official said on Thursday. A government circular in this regard ha...

Will other states need to have election to get vaccinated against COVID-19, asks Salman Khurshid

Taking a dig at BJPs manifesto for poll-bound Bihar where it promised free COVID-19 vaccine for all if it came to power, senior Congress leader Salman Khurshid on Thursday asked if all states need to have assembly elections in order to get ...

Pak PM Khan speaks to Bhutanese counterpart

Pakistan Prime Minister Imran Khan on Thursday spoke to his Bhutanese counterpart Lotay Tshering and underscored the importance Pakistan attaches to its ties with Bhutan. Khan highlighted the significance of regular bilateral contacts and p...

Give Feedback